These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10207352)

  • 21. Important drug information: immune globulin intravenous (human).
    Epstein JS; Gaines A; Kapit R; Pierce R; Potter R; Varricchio F
    Int J Trauma Nurs; 1999; 5(4):139-40. PubMed ID: 10661146
    [No Abstract]   [Full Text] [Related]  

  • 22. Potential safety signals and their significance.
    Powers A; Cook GE
    Arch Intern Med; 2012 Jan; 172(1):72-3. PubMed ID: 22082712
    [No Abstract]   [Full Text] [Related]  

  • 23. Impairment of renal function after intravenous immunoglobulin.
    Soares SM; Sethi S
    Nephrol Dial Transplant; 2006 Mar; 21(3):816-7. PubMed ID: 16399766
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravenous immune globulin for multiple sclerosis.
    Tecnologica MAP Suppl; 1998 Aug; ():3-5. PubMed ID: 10342975
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience.
    Vo AA; Cam V; Toyoda M; Puliyanda DP; Lukovsky M; Bunnapradist S; Peng A; Yang K; Jordan SC
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):844-52. PubMed ID: 17699296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse drug reaction reporting.
    Somberg JC
    Am J Ther; 2000 Aug; 7(4):227-8. PubMed ID: 11486155
    [No Abstract]   [Full Text] [Related]  

  • 27. Lessons from cisapride.
    CMAJ; 2001 May; 164(9):1269, 1271. PubMed ID: 11341130
    [No Abstract]   [Full Text] [Related]  

  • 28. Panel backs pain drug studies with new safety checks.
    Dolgin E
    Nat Med; 2012 Apr; 18(4):472. PubMed ID: 22481387
    [No Abstract]   [Full Text] [Related]  

  • 29. Adverse drug reactions in Canada. Hematologic reactions to sterol and sterolin-containing products.
    Can Fam Physician; 2004 Aug; 50():1115-6. PubMed ID: 15455811
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acute renal failure following treatment with intravenously administered immunoglobulins].
    van Zanten AR; Beekhuyzen M; van der Meer YG; de Gooijer A; Feith GW
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):307-10. PubMed ID: 12622009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisapride and patient information leaflets.
    Sukkari SR; Sasich LD
    CMAJ; 2001 May; 164(9):1276-8; author reply 1278-9. PubMed ID: 11341134
    [No Abstract]   [Full Text] [Related]  

  • 32. Statin safety: an appraisal from the adverse event reporting system.
    Davidson MH; Clark JA; Glass LM; Kanumalla A
    Am J Cardiol; 2006 Apr; 97(8A):32C-43C. PubMed ID: 16581327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse drug reaction reporting--2000: Part 2.
    Sutcliffe H; Macdonald L
    CMAJ; 2001 Jul; 165(1):83, 87. PubMed ID: 11468964
    [No Abstract]   [Full Text] [Related]  

  • 34. Summary of adverse event reports for veterinary biologic products received by the USDA from 1999 through 2005.
    Frana TS; Elsken LA; Karli SA
    J Am Vet Med Assoc; 2006 Oct; 229(7):1100-2. PubMed ID: 17014356
    [No Abstract]   [Full Text] [Related]  

  • 35. Toward improved adverse event/suspected adverse drug reaction reporting.
    Gross R; Strom BL
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):89-91. PubMed ID: 12642971
    [No Abstract]   [Full Text] [Related]  

  • 36. Adverse drug reactions and reporting.
    Witte R
    Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccine adverse event reporting: the importance of follow-up.
    Varricchio F
    Expert Rev Vaccines; 2005 Aug; 4(4):445-8. PubMed ID: 16117700
    [No Abstract]   [Full Text] [Related]  

  • 38. Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: an overview of reports, 2003-2007.
    Johann-Liang R; Wyeth J; Chen M; Cope JU
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):24-7. PubMed ID: 19009550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reporting adverse vaccine events.
    O'Rourke K
    J Am Vet Med Assoc; 2003 Sep; 223(6):753-4. PubMed ID: 14507079
    [No Abstract]   [Full Text] [Related]  

  • 40. The state of dietary supplement adverse event reporting in the United States.
    Gardiner P; Sarma DN; Low Dog T; Barrett ML; Chavez ML; Ko R; Mahady GB; Marles RJ; Pellicore LS; Giancaspro GI
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):962-70. PubMed ID: 18613260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.